The first dedicated fund for autism innovation.
Investing in life science breakthroughs & therapeutics, digital health, education, and life beyond childhood.
Concentrating capital, expertise, and community to accelerate advances in autism.
Solid. Experienced. Motivated.
Led by a team of cross-functional domain experts.
Best-selling author and Marketing Strategist
Tom Insel, MD
Former Director, Co-founder Mindstrong, NIMH for 13 years
Chair of Genomics and Personalized Medicine, Stanford University School of Medicine
Sprout Group 20+ years private equity investor
Bold strategy + Biology + Technology = Audacious goal achieved.